Poole Presenting NuCalm at the 20th Annual Brain Mapping & Therapeutics Conference
JIM POOLE, PRESIDENT/CEO OF NUCALM, TO SPEAK ON THERAPEUTIC NEUROSCIENCE TREATMENT AT SBMT CONGRESS FRIDAY, FEBRUARY 17
20th Annual Congress of the Society for Brain Mapping and Therapeutics to take place at Los Angeles Convention Center
‘The Power of NuCalm in Addiction, PTSD and Trauma Treatment’ to be Discussed in Brain Science Presentation
LOS ANGELES, CA (Issued February 16, 2023) — Jim Poole, President/CEO of NuCalm, where stress surrenders to neuroscience, will lecture at the 20th Annual Congress of the Society for Brain Mapping and Therapeutics (SBMT) on Friday February 17 at 3:30 p.m. The SBMT Congress is of one of the most prestigious events in brain science, Brain Mapping and Intra-operative Surgical Planning. It is being held at the Los Angeles Convention Center.
Poole will present the lecture ‘Downregulation of Sympathetic Tone in Substance Use Withdrawal and Relapse Prevention - a Patented Clinically Proven Therapeutic Intervention – NuCalm’ with Dr. Keerthy Sunder, physician, psychiatrist and Assistant Clinical Professor, University of California, Riverside, CA. The two are leading the research and treatment of trauma treatment and brain science.
“I am honored to join Dr. Sunder in presenting our research and insights with NuCalm. We are focused on creating all-natural stress relief technology that is based on the technology of brain health,” said Poole. “The SBMT is a well-regarded symposium that brings leading practices and research to the industry, and we are excited to share our findings.”
The SBMT is a non-profit biomedical association principally concerned with Brain Mapping and Intra- operative Surgical Planning. www.worldbrainmapping.org/Annual-Congress/ The SBMT Congress brings together physicians, scientists, policymakers, funding agencies, and industry to further the advances and applications in brain and spinal cord mapping and image-guided therapies.
Dr Sunder, CEO of Karma Doctors & Karma TMS, Inc., recommends NuCalm in a clinical environment to help restore patient health without drugs. Poole says the technology helps people manage addiction,
PTSD, and trauma in a proven healing process. The technology solves stress at the midbrain and allows the body and mind to relax, restore, and recover without drugs,” said Poole.
Dr. Sunder’s approach to dealing with anxiety and depression involves integrative psychiatry addressing the power of the mind and chemistry of the brain to deliver powerful results. Sunder says, “Our team delivers care at the intersection of science, tradition and compassion, and NuCalm is an anchor therapeutic intervention for our treatment protocol.”
NuCalm enables users to manage their recovery on demand, through its proven and researched protocols available on its mobile app. NuCalm can provide two hours of restorative sleep in just 20 minutes, which has been supported by research from Harvard Medical School statistical biophysicists. Backed by 33 years
of research and development, the company offers paid monthly subscriptions on its website and mobile app.
“The world is a stress-filled place and with NuCalm we are making a profound impact on millions of people’s lives,” said Poole. “We are determined to make our patented, clinically proven technology easy to use and affordable. NuCalm stops stress and allows you to relax; It’s our mission to help those who need support,
and over the past 14 years we have not met many people who couldn’t benefit from lowering their stress and improving their sleep quality without drugs.” To see testimonials, information on its partner network, and pricing go here: www.NuCalm.com
CONTACT:
For more info and/or interviews, contact David Poole, Chief Business Officer: david.poole@nucalm.com . Visit website: www.NuCalm.com
Dr. Keerthy Sunder
Jim Poole